The Oxford Classic links epithelial-mesenchymal transition to immunosuppression in poor prognosis ovarian cancers
Purpose: Using RNA sequencing, we recently developed the 52-gene–based Oxford classifier of carcinoma of the ovary (Oxford Classic, OxC) for molecular stratification of serous ovarian cancers (SOCs) based on the molecular profiles of their cell of origin in the fallopian tube epithelium. Here, we de...
| Main Authors: | , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
American Association for Cancer Research
2021
|
| _version_ | 1797065223836794880 |
|---|---|
| author | Hu, Z Cunnea, P Zhong, Z Lu, H Osagie, OI Campo, L Artibani, M Nixon, K Ploski, J Gonzalez, LS Alsaadi, A Wietek, N Damato, S Dhar, S Blagden, S Yau, C Hester, J Albukhari, A Aboagye, EO Fotopoulou, C Ahmed, A |
| author_facet | Hu, Z Cunnea, P Zhong, Z Lu, H Osagie, OI Campo, L Artibani, M Nixon, K Ploski, J Gonzalez, LS Alsaadi, A Wietek, N Damato, S Dhar, S Blagden, S Yau, C Hester, J Albukhari, A Aboagye, EO Fotopoulou, C Ahmed, A |
| author_sort | Hu, Z |
| collection | OXFORD |
| description | Purpose: Using RNA sequencing, we recently developed the 52-gene–based Oxford classifier of carcinoma of the ovary (Oxford Classic, OxC) for molecular stratification of serous ovarian cancers (SOCs) based on the molecular profiles of their cell of origin in the fallopian tube epithelium. Here, we developed a 52-gene NanoString panel for the OxC to test the robustness of the classifier.
Experimental Design: We measured the expression of the 52 genes in an independent cohort of prospectively collected SOC samples (n = 150) from a homogenous cohort who were treated with maximal debulking surgery and chemotherapy. We performed data mining of published expression profiles of SOCs and validated the classifier results on tissue arrays comprising 137 SOCs.
Results: We found evidence of profound nongenetic heterogeneity in SOCs. Approximately 20% of SOCs were classified as epithelial-to-mesenchymal transition–high (EMT-high) tumors, which were associated with poor survival. This was independent of established prognostic factors, such as tumor stage, tumor grade, and residual disease after surgery (HR, 3.3; P = 0.02). Mining expression data of 593 patients revealed a significant association between the EMT scores of tumors and the estimated fraction of alternatively activated macrophages (M2; P < 0.0001), suggesting a mechanistic link between immunosuppression and poor prognosis in EMT-high tumors.
Conclusions: The OxC-defined EMT-high SOCs carry particularly poor prognosis independent of established clinical parameters. These tumors are associated with high frequency of immunosuppressive macrophages, suggesting a potential therapeutic target to improve clinical outcome.
|
| first_indexed | 2024-03-06T21:25:35Z |
| format | Journal article |
| id | oxford-uuid:42fdb2af-95d1-40b4-9851-d10cd3842f18 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-06T21:25:35Z |
| publishDate | 2021 |
| publisher | American Association for Cancer Research |
| record_format | dspace |
| spelling | oxford-uuid:42fdb2af-95d1-40b4-9851-d10cd3842f182022-03-26T14:52:43ZThe Oxford Classic links epithelial-mesenchymal transition to immunosuppression in poor prognosis ovarian cancersJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:42fdb2af-95d1-40b4-9851-d10cd3842f18EnglishSymplectic ElementsAmerican Association for Cancer Research2021Hu, ZCunnea, PZhong, ZLu, HOsagie, OICampo, LArtibani, MNixon, KPloski, JGonzalez, LSAlsaadi, AWietek, NDamato, SDhar, SBlagden, SYau, CHester, JAlbukhari, AAboagye, EOFotopoulou, CAhmed, APurpose: Using RNA sequencing, we recently developed the 52-gene–based Oxford classifier of carcinoma of the ovary (Oxford Classic, OxC) for molecular stratification of serous ovarian cancers (SOCs) based on the molecular profiles of their cell of origin in the fallopian tube epithelium. Here, we developed a 52-gene NanoString panel for the OxC to test the robustness of the classifier. Experimental Design: We measured the expression of the 52 genes in an independent cohort of prospectively collected SOC samples (n = 150) from a homogenous cohort who were treated with maximal debulking surgery and chemotherapy. We performed data mining of published expression profiles of SOCs and validated the classifier results on tissue arrays comprising 137 SOCs. Results: We found evidence of profound nongenetic heterogeneity in SOCs. Approximately 20% of SOCs were classified as epithelial-to-mesenchymal transition–high (EMT-high) tumors, which were associated with poor survival. This was independent of established prognostic factors, such as tumor stage, tumor grade, and residual disease after surgery (HR, 3.3; P = 0.02). Mining expression data of 593 patients revealed a significant association between the EMT scores of tumors and the estimated fraction of alternatively activated macrophages (M2; P < 0.0001), suggesting a mechanistic link between immunosuppression and poor prognosis in EMT-high tumors. Conclusions: The OxC-defined EMT-high SOCs carry particularly poor prognosis independent of established clinical parameters. These tumors are associated with high frequency of immunosuppressive macrophages, suggesting a potential therapeutic target to improve clinical outcome. |
| spellingShingle | Hu, Z Cunnea, P Zhong, Z Lu, H Osagie, OI Campo, L Artibani, M Nixon, K Ploski, J Gonzalez, LS Alsaadi, A Wietek, N Damato, S Dhar, S Blagden, S Yau, C Hester, J Albukhari, A Aboagye, EO Fotopoulou, C Ahmed, A The Oxford Classic links epithelial-mesenchymal transition to immunosuppression in poor prognosis ovarian cancers |
| title | The Oxford Classic links epithelial-mesenchymal transition to immunosuppression in poor prognosis ovarian cancers |
| title_full | The Oxford Classic links epithelial-mesenchymal transition to immunosuppression in poor prognosis ovarian cancers |
| title_fullStr | The Oxford Classic links epithelial-mesenchymal transition to immunosuppression in poor prognosis ovarian cancers |
| title_full_unstemmed | The Oxford Classic links epithelial-mesenchymal transition to immunosuppression in poor prognosis ovarian cancers |
| title_short | The Oxford Classic links epithelial-mesenchymal transition to immunosuppression in poor prognosis ovarian cancers |
| title_sort | oxford classic links epithelial mesenchymal transition to immunosuppression in poor prognosis ovarian cancers |
| work_keys_str_mv | AT huz theoxfordclassiclinksepithelialmesenchymaltransitiontoimmunosuppressioninpoorprognosisovariancancers AT cunneap theoxfordclassiclinksepithelialmesenchymaltransitiontoimmunosuppressioninpoorprognosisovariancancers AT zhongz theoxfordclassiclinksepithelialmesenchymaltransitiontoimmunosuppressioninpoorprognosisovariancancers AT luh theoxfordclassiclinksepithelialmesenchymaltransitiontoimmunosuppressioninpoorprognosisovariancancers AT osagieoi theoxfordclassiclinksepithelialmesenchymaltransitiontoimmunosuppressioninpoorprognosisovariancancers AT campol theoxfordclassiclinksepithelialmesenchymaltransitiontoimmunosuppressioninpoorprognosisovariancancers AT artibanim theoxfordclassiclinksepithelialmesenchymaltransitiontoimmunosuppressioninpoorprognosisovariancancers AT nixonk theoxfordclassiclinksepithelialmesenchymaltransitiontoimmunosuppressioninpoorprognosisovariancancers AT ploskij theoxfordclassiclinksepithelialmesenchymaltransitiontoimmunosuppressioninpoorprognosisovariancancers AT gonzalezls theoxfordclassiclinksepithelialmesenchymaltransitiontoimmunosuppressioninpoorprognosisovariancancers AT alsaadia theoxfordclassiclinksepithelialmesenchymaltransitiontoimmunosuppressioninpoorprognosisovariancancers AT wietekn theoxfordclassiclinksepithelialmesenchymaltransitiontoimmunosuppressioninpoorprognosisovariancancers AT damatos theoxfordclassiclinksepithelialmesenchymaltransitiontoimmunosuppressioninpoorprognosisovariancancers AT dhars theoxfordclassiclinksepithelialmesenchymaltransitiontoimmunosuppressioninpoorprognosisovariancancers AT blagdens theoxfordclassiclinksepithelialmesenchymaltransitiontoimmunosuppressioninpoorprognosisovariancancers AT yauc theoxfordclassiclinksepithelialmesenchymaltransitiontoimmunosuppressioninpoorprognosisovariancancers AT hesterj theoxfordclassiclinksepithelialmesenchymaltransitiontoimmunosuppressioninpoorprognosisovariancancers AT albukharia theoxfordclassiclinksepithelialmesenchymaltransitiontoimmunosuppressioninpoorprognosisovariancancers AT aboagyeeo theoxfordclassiclinksepithelialmesenchymaltransitiontoimmunosuppressioninpoorprognosisovariancancers AT fotopoulouc theoxfordclassiclinksepithelialmesenchymaltransitiontoimmunosuppressioninpoorprognosisovariancancers AT ahmeda theoxfordclassiclinksepithelialmesenchymaltransitiontoimmunosuppressioninpoorprognosisovariancancers AT huz oxfordclassiclinksepithelialmesenchymaltransitiontoimmunosuppressioninpoorprognosisovariancancers AT cunneap oxfordclassiclinksepithelialmesenchymaltransitiontoimmunosuppressioninpoorprognosisovariancancers AT zhongz oxfordclassiclinksepithelialmesenchymaltransitiontoimmunosuppressioninpoorprognosisovariancancers AT luh oxfordclassiclinksepithelialmesenchymaltransitiontoimmunosuppressioninpoorprognosisovariancancers AT osagieoi oxfordclassiclinksepithelialmesenchymaltransitiontoimmunosuppressioninpoorprognosisovariancancers AT campol oxfordclassiclinksepithelialmesenchymaltransitiontoimmunosuppressioninpoorprognosisovariancancers AT artibanim oxfordclassiclinksepithelialmesenchymaltransitiontoimmunosuppressioninpoorprognosisovariancancers AT nixonk oxfordclassiclinksepithelialmesenchymaltransitiontoimmunosuppressioninpoorprognosisovariancancers AT ploskij oxfordclassiclinksepithelialmesenchymaltransitiontoimmunosuppressioninpoorprognosisovariancancers AT gonzalezls oxfordclassiclinksepithelialmesenchymaltransitiontoimmunosuppressioninpoorprognosisovariancancers AT alsaadia oxfordclassiclinksepithelialmesenchymaltransitiontoimmunosuppressioninpoorprognosisovariancancers AT wietekn oxfordclassiclinksepithelialmesenchymaltransitiontoimmunosuppressioninpoorprognosisovariancancers AT damatos oxfordclassiclinksepithelialmesenchymaltransitiontoimmunosuppressioninpoorprognosisovariancancers AT dhars oxfordclassiclinksepithelialmesenchymaltransitiontoimmunosuppressioninpoorprognosisovariancancers AT blagdens oxfordclassiclinksepithelialmesenchymaltransitiontoimmunosuppressioninpoorprognosisovariancancers AT yauc oxfordclassiclinksepithelialmesenchymaltransitiontoimmunosuppressioninpoorprognosisovariancancers AT hesterj oxfordclassiclinksepithelialmesenchymaltransitiontoimmunosuppressioninpoorprognosisovariancancers AT albukharia oxfordclassiclinksepithelialmesenchymaltransitiontoimmunosuppressioninpoorprognosisovariancancers AT aboagyeeo oxfordclassiclinksepithelialmesenchymaltransitiontoimmunosuppressioninpoorprognosisovariancancers AT fotopoulouc oxfordclassiclinksepithelialmesenchymaltransitiontoimmunosuppressioninpoorprognosisovariancancers AT ahmeda oxfordclassiclinksepithelialmesenchymaltransitiontoimmunosuppressioninpoorprognosisovariancancers |